[RituximabB:]

Lan Yang1, Li-Xia Cao1, Hui-Juan Ren1

  • 1Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, Inner Mongolia Autonomous Region, China.

概括

主要的外扩散性大B细胞淋巴瘤 (DLBCL) 最常见的是涉及胃肠道,预后较差. NCCN-IPI得分是这些患者生存结果的关键预测指标.